alexa A Prospective Study On Chemotherapy Induced Anemia In Cancer Patients Undergoing Treatment Using Serial Hemoglobin Measurement At The National Hospital Abuja, Nigeria
ISSN: 2161-0932

Gynecology & Obstetrics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd Annual Conference on Gynecologic Oncology & Preventive Oncology
July 20-21, 2017 Chicago, USA

Aruah S C
National Hospital Abuja, Nigeria
Posters & Accepted Abstracts: Gynecol Obstet (Sunnyvale)
DOI: 10.4172/2161-0932-C1-016
Abstract
Introduction: Anemia is a common complication of myelo-suppressive chemotherapy. Severe anemia is usually treated with red blood cell transfusion; however, mild-to-moderate anemia most often is managed conservatively. There is no universally established benchmark of hemoglobin of patients selected for cancer chemotherapy to inform a global best practice and increase patients treatment outcome and quality of life. Objective: To examine the change in Hb level of cancer patients undergoing chemotherapy using serial Hb measurement. Materials & Methods: A total of 100 voluntary patients with solid malignancies were recruited within a period of 8 months. Baseline demographic characteristics and type of tumor were obtained. Pre-treatment Hb level was measured on first day of consultation and repeated every 2 weeks during the therapy until after three consecutive Hb readings. Results: Data collected was analyzed using SPSS version 10. Out of the 100 cancer patients, 88% were female. Breast 68% (68) was commonest site of tumor. Prevalence of anemia in the study was 72% and majority of patients had their Hb at the end of therapy within the range of 9.60 to 10.62 g/dl. At P-value>0.05, there was no statistical significance on distribution of mean hemoglobin, standard deviation based on sex and treatment type. Conclusion/Recommendation: Chemotherapy has no significant effect on Hb especially in patients with high baseline Hb level between 11 g/dl to 12 g/dl in our study. Prevalence of anemia in the studied patients was 72%. We recommend a benchmark of Hb of 11 g/dl minimum for any patient being selected for chemotherapy in Nigeria.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords